Page last updated: 2024-11-03

rimantadine and Idiopathic Parkinson Disease

rimantadine has been researched along with Idiopathic Parkinson Disease in 2 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Research Excerpts

ExcerptRelevanceReference
"We report our experience with 7 consecutive patients with Parkinson's disease (PD) who received rimantadine (the alpha-methyl derivative of amantadine) in substitution of amantadine due to peripheral side effects (lower limb edema, livedo reticularis)."5.11Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series. ( Gonzalez, MA; Lieberman, A; Papapetropoulos, S; Roberts, EL; Singer, C, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duque, MD1
Camps, P1
Torres, E1
Valverde, E1
Sureda, FX1
López-Querol, M1
Camins, A1
Prathalingam, SR1
Kelly, JM1
Vázquez, S1
Singer, C1
Papapetropoulos, S1
Gonzalez, MA1
Roberts, EL1
Lieberman, A1

Trials

1 trial available for rimantadine and Idiopathic Parkinson Disease

ArticleYear
Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:7

    Topics: Aged; Amantadine; Antiparkinson Agents; Edema; Female; Humans; Middle Aged; Motor Activity; Parkinso

2005

Other Studies

1 other study available for rimantadine and Idiopathic Parkinson Disease

ArticleYear
New oxapolycyclic cage amines with NMDA receptor antagonist and trypanocidal activities.
    Bioorganic & medicinal chemistry, 2010, Jan-01, Volume: 18, Issue:1

    Topics: Amines; Animals; Antiparkinson Agents; Cells, Cultured; Humans; Memantine; Molecular Structure; Neur

2010